We are live on ! Find out more
PMC

PharMerica Corporation
PMC

Delisted

PMC was delisted on the 7th of December, 2017.

158 hedge funds and large institutions have $627M invested in PharMerica Corporation in 2013 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 53 increasing their positions, 59 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 14

67% more capital invested

Capital invested by funds: $375M → $627M (+$252M)

7% more funds holding

Funds holding: 147158 (+11)

10% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 59

24% less call options, than puts

Call options by funds: $492K | Put options by funds: $645K

Holders
158
Holders Change
+11
Holders Change %
+7.48%
% of All Funds
4.59%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
25
Increased
53
Reduced
59
Closed
14
Calls
$492K
Puts
$645K
Net Calls
-$153K
Net Calls Change
-$159K
Name Holding Trade Value Shares
Change
Change in
Stake
HA
1
Heartland Advisors
Wisconsin
$54.5M -$12M -661,909 -21%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$40.5M +$2.24M +123,431 +7%
BFA
3
BlackRock Fund Advisors
California
$38M +$231K +12,718 +0.7%
LSV Asset Management
4
LSV Asset Management
Illinois
$34.9M -$1.48M -81,406 -5%
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$25.6M +$132K +7,288 +0.6%
Vanguard Group
6
Vanguard Group
Pennsylvania
$22.6M +$3.13M +172,079 +20%
BIT
7
BlackRock Institutional Trust
California
$21.3M -$1.37M -75,224 -7%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$19M +$15.8M +871,758 +6,375%
Bank of America
9
Bank of America
North Carolina
$18.4M +$1.94M +106,766 +14%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$17.6M -$296K -16,265 -2%
KIM
11
Kestrel Investment Management
California
$14.5M -$2.49M -136,900 -17%
SFM
12
Systematic Financial Management
New Jersey
$14.1M +$9.77M +537,480 +461%
SGCIA
13
Smith Graham & Co Investment Advisors
Texas
$13.7M -$28.4K -1,560 -0.2%
State Street
14
State Street
Massachusetts
$12.9M -$753K -41,450 -6%
KCM
15
Kennedy Capital Management
Missouri
$11.5M +$1.82M +100,344 +23%
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$10.4M +$445K +24,497 +5%
American Century Companies
17
American Century Companies
Missouri
$10.4M -$2.38M -131,188 -21%
GAM
18
Gotham Asset Management
New York
$9.77M +$4.34M +238,793 +111%
Northern Trust
19
Northern Trust
Illinois
$9.67M -$811K -44,643 -9%
Fuller & Thaler Asset Management
20
Fuller & Thaler Asset Management
California
$8.06M -$3.29M -181,083 -33%
Ameriprise
21
Ameriprise
Minnesota
$7.63M +$4.37M +240,637 +211%
TAM
22
THB Asset Management
Connecticut
$7.48M +$6.33M +347,977 New
RFC
23
Russell Frank Company
Washington
$7.3M -$542K -29,842 -9%
NI
24
Numeric Investors
Massachusetts
$7.25M -$1.21M -66,646 -16%
TC
25
TFS Capital
Pennsylvania
$6.59M +$2.23M +122,409 +67%

PMC Hedge Fund Activity: Q4 2013 in Review

158 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in PharMerica Corporation (PMC) for Q4 2013, worth a combined $627M — up 67% from $375M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new PMC positions and 14 closed out — a net gain of 11 holders — while 53 added to existing stakes and 59 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $15.8M. The largest seller was Hotchkis & Wiley Capital Management, exiting entirely with an estimated $17M sold.

  • 158 institutional investors held PharMerica Corporation (PMC) as of Q4 2013, up from 147 in Q3 2013.
  • Funds reported $627M of PharMerica Corporation stock for Q4 2013, up 67% quarter-over-quarter.
  • 25 funds opened new PharMerica Corporation positions in Q4 2013 and 14 closed out, a net change of +11 holders.
  • The largest PharMerica Corporation buyer in Q4 2013 was Fidelity Investments, an estimated $15.8M added.
  • The largest PharMerica Corporation seller in Q4 2013 was Hotchkis & Wiley Capital Management, an estimated $17M sold.

Based on aggregated 13F filings for Q4 2013.